Sector Gamma As Ultragenyx Pharmaceutical Inc. Transaction History

Sector Gamma As

$309 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$31.73 - $49.19 $402,209 - $623,532	-12,676 Reduced 11.01%	102,490 $4.9 Million
Q3 2023 Nov 06, 2023	BUY	$34.92 - $46.66 $508,470 - $679,416	14,561 Added 14.47%	115,166 $4.11 Million
Q2 2023 Aug 09, 2023	SELL	$37.35 - $52.15 $212,035 - $296,055	-5,677 Reduced 5.34%	100,605 $4.64 Million
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $2.25 Million - $2.96 Million	60,762 Added 133.48%	106,282 $4.26 Million
Q3 2022 Nov 09, 2022	SELL	$39.96 - $66.14 $28,011 - $46,364	-701 Reduced 1.52%	45,520 $1.89 Million
Q1 2022 May 06, 2022	BUY	$62.2 - $84.4 $2.87 Million - $3.9 Million	46,221 New	46,221 $3.36 Million
Q3 2020 Nov 09, 2020	SELL	$72.98 - $90.0 $7.94 Million - $9.79 Million	-108,734 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$46.91 - $78.22 $1.7 Million - $2.84 Million	-36,338 Reduced 25.05%	108,734 $8.51 Million
Q1 2020 May 11, 2020	SELL	$33.8 - $62.9 $2.37 Million - $4.41 Million	-70,124 Reduced 32.59%	145,072 $6.45 Million
Q4 2019 Feb 12, 2020	BUY	$36.08 - $45.83 $1.52 Million - $1.93 Million	42,218 Added 24.41%	215,196 $9.19 Million
Q3 2019 Nov 05, 2019	BUY	$42.5 - $63.11 $3.97 Million - $5.89 Million	93,325 Added 117.16%	172,978 $7.4 Million
Q2 2019 Jul 31, 2019	BUY	$54.93 - $74.36 $753,529 - $1.02 Million	13,718 Added 20.81%	79,653 $5.06 Million
Q1 2019 May 13, 2019	BUY	$39.87 - $69.36 $2.31 Million - $4.02 Million	57,935 Added 724.19%	65,935 $4.57 Million
Q4 2018 Feb 12, 2019	SELL	$38.89 - $77.3 $831,001 - $1.65 Million	-21,368 Reduced 72.76%	8,000 $348,000
Q3 2018 Nov 15, 2018	BUY	$71.81 - $90.15 $1.04 Million - $1.3 Million	14,429 Added 96.59%	29,368 $2.24 Million
Q3 2018 Nov 08, 2018	SELL	$71.81 - $90.15 $3.81 Million - $4.78 Million	-53,076 Reduced 78.04%	14,939 $1.14 Million
Q2 2018 Aug 02, 2018	BUY	$48.54 - $85.31 $3.3 Million - $5.8 Million	68,015 New	68,015 $5.23 Million

Others Institutions Holding RARE

# of Institutions

324

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$427 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$241 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$220 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$179 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$132 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.

Account